{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [],
   "source": [
    "import nltk\n",
    "import spacy\n",
    "import pandas as pd\n",
    "from tqdm import tqdm\n",
    "import os\n",
    "import nltk\n",
    "import numpy as np\n",
    "from pattern.text.en import singularize\n",
    "import nltk\n",
    "from nltk.corpus import stopwords\n",
    "stop_words = stopwords.words('english')\n",
    "import pickle\n",
    "from collections import Counter"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "3"
      ]
     },
     "execution_count": 1,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "1+2"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Getting sentence classifications"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {},
   "outputs": [],
   "source": [
    "f = open(\"LitCovid_sent_classification_formatted.sents\", \"r\")\n",
    "sec_class_sents = f.read()\n",
    "f = open(\"LitCovid_sent_classification_formatted.txt\", \"r\")\n",
    "sec_class_txt = f.read()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "ename": "NameError",
     "evalue": "name 'sec_pmids' is not defined",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mNameError\u001b[0m                                 Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-4-f2827fad216a>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m()\u001b[0m\n\u001b[1;32m----> 1\u001b[1;33m \u001b[0msec_pmids\u001b[0m\u001b[1;33m[\u001b[0m\u001b[1;36m6469\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m",
      "\u001b[1;31mNameError\u001b[0m: name 'sec_pmids' is not defined"
     ]
    }
   ],
   "source": [
    "sec_pmids[6469]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {},
   "outputs": [],
   "source": [
    "sec_classes = sec_class_sents.split(\"\\n\\n\\n\")\n",
    "sec_pmids = [t.split(\" | \")[0] for t in sec_class_txt.split(\"\\n\")]\n",
    "sections = {}\n",
    "for i in range(len(sec_pmids)):\n",
    "    if sec_pmids[i] != \"\":\n",
    "        sections[sec_pmids[i]] = [(t.split(\"||\")[0], t.split(\"||\")[1]) for t in sec_classes[i].split(\"\\n\")]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "100%|███████████████████████████████████████████████████████████████████████████| 6470/6470 [00:00<00:00, 12750.56it/s]\n"
     ]
    }
   ],
   "source": [
    "split_sections = {}\n",
    "for i in tqdm(range(len(sec_pmids))):\n",
    "    if sec_pmids[i] != \"\":\n",
    "        sect = sections[sec_pmids[i]]\n",
    "        temp_sect = []\n",
    "        for line in sect:\n",
    "            if len(line[1].split()) > 30:\n",
    "                text = line[1].split()\n",
    "#                 print(text)\n",
    "                split_sentences = [' '.join(text[i:i+30]) for i in range(0, len(text),30)]\n",
    "#                 print(split_sentences)\n",
    "                for sent in split_sentences:\n",
    "                    temp_sect.append((line[0], sent))\n",
    "            else:\n",
    "                temp_sect.append(line)\n",
    "        \n",
    "        split_sections[sec_pmids[i]] = temp_sect"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 115,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'47.0(38.0-70.3)'"
      ]
     },
     "execution_count": 115,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "import re\n",
    "t  = \"They had a median ( interquartile range [ IQR ] ) age of 47.0 ( 38.0-70.3 ) years , and 16 ( 38.1 % ) were men .\".split()\n",
    "age = \"\".join(t[t.index(\"age\")+1:t.index(\"years\")])\n",
    "regex = re.compile('[a-zA-Z]')\n",
    "regex.sub('', age)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 112,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'>=75'"
      ]
     },
     "execution_count": 112,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "age"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 136,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('TITLE', 'Coronavirus infections and immune responses'),\n",
       " ('BACKGROUND',\n",
       "  'Coronaviruses ( CoVs ) are by far the largest group of known positive - sense RNA viruses having an extensive range of natural hosts .'),\n",
       " ('BACKGROUND',\n",
       "  'In the past few decades , newly evolved Coronaviruses have posed a global threat to public health .'),\n",
       " ('BACKGROUND',\n",
       "  'The immune response is essential to control and eliminate CoV infections , however , maladjusted immune responses may result in immunopathology and impaired pulmonary gas exchange .'),\n",
       " ('BACKGROUND',\n",
       "  'Gaining a deeper understanding of the interaction between Coronaviruses and the innate immune systems of the hosts may shed light on the development and persistence of inflammation in the lungs and hopefully can reduce the risk of lung inflammation caused by CoVs .'),\n",
       " ('CONCLUSIONS',\n",
       "  'In this review , we provide an update on CoV infections and relevant diseases , particularly the host defense against CoV - induced inflammation of lung tissue , as well as the role of the innate immune system in the pathogenesis and clinical treatment .'),\n",
       " ('CONCLUSIONS',\n",
       "  'HIGHLIGHTS : This highlights the importance of immune responses under coronavirus infection and improve the understanding of the features of CoV - induced inflammatory response .')]"
      ]
     },
     "execution_count": 136,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# sec_classes[i].split(\"\\n\")\n",
    "sections.get(\"31981224\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 122,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "custom_syns = [['COVID-19', \"SARS-CoV-2\", \"SARS-CoV-2 infection\", \"COVID-19 infection\", \n",
    "  \"coronavirus disease 2019 ( COVID-19 )\", 'Covid-19', 'laboratory-confirmed COVID-19', \n",
    "  \"coronavirus disease 2019\", \"COVID-19 disease\", \"coronavirus disease\", \"SARS-CoV\", \n",
    "  \"COVID-19 positive\", \"SARS-COV-2\", \"SARS-CoV-2 infections\",  \"Covid-19 infection\", \n",
    "  \"COVID-19 infected\", \"COVID-19-positive\", \"SARS-CoV-2 infected\", \"SARS-CoV-2-infected\",\n",
    "  \"2019-nCoV\", \"COVID-19 infections\", \"COVID 19\", \"COVID19\", \"Covid-19 infection\",\n",
    "  \"severe acute respiratory syndrome coronavirus 2 ( SARS-CoV-2 ) infection\", \n",
    "  'coronavirus disease ( COVID-19 )', \"CoV infections\", \"coronavirus\", \"2019-new coronavirus\",\n",
    "  \"SARS-CoV-2 virus\", \"coronavirus infections\"],\n",
    " [\"severe COVID-19\", \"severe and critical COVID-19\", \"severe COVID-19 infection\", \n",
    "  'severe coronavirus disease 2019 ( COVID-19 )',\n",
    "  'severe coronavirus disease 2019 ( COVID-19 )', \n",
    "  'severe acute respiratory syndrome ( SARS )', 'severe and critical COVID-19',\n",
    "  'severe acute respiratory syndrome coronavirus 2',\n",
    "  'critically ill COVID-19', \"severe COVID-19 disease\"],\n",
    " [\"severe COVID-19 pneumonia\", \"severe pneumonia\", \"COVID-19 pneumonia\", \"SARS-CoV-2 pneumonia\",\n",
    "  'novel coronavirus pneumonia', \"2019-nCoV pneumonia\"],\n",
    " [\"male\", \"men\", \"males\", \"male sex\"],\n",
    " [\"infection\", \"infected\"],\n",
    " [\"female\", \"women\", \"females\", \"female sex\"],\n",
    " [\"severe\", \"severe disease\", \"severe cases\", \"severely ill\", \"severe illness\"],\n",
    " [\"critical\", \"critically ill\",  \"critical illness\"],\n",
    " [\"comorbidity\", \"comorbidities\"],\n",
    " [\"ICU\", \"intensive care unit ( ICU )\", \"intensive care\"],\n",
    " [\"diabetes\", \"diabetes mellitus\", \"diabetic\"],\n",
    " [\"elderly\", \"older age\", \"older adults\", \"older\"],\n",
    " [\"hydroxychloroquine\", \"chloroquine\", \"hcq\"],\n",
    " [\"dead\", \"deceased\", \"mortality\", \"died\", \"death\"]]\n",
    "\n",
    "severe_subtags = [\n",
    "    [\"infection\", \"infections\", \"cases\", \"case\", \"outcomes\", \"outcome\", \"disease\", \"patient\", \"patients\", \"group\"],\n",
    "    [\"pneumonia\", \"event\", \"events\", \"complications\", \"complication\", \"diabetes\", \"disease\"],\n",
    "    [\"fever\", \"acute\", \"ards\", \"acidosis\", \"hypercoagulability\", \"inflammatory\", \"inflammation\"],\n",
    "    [\"course\", \"courses\", \"stages\", \"stage\"]]\n",
    "\n",
    "severe_subtags_names = [\"COVID-19\", \"other diseases\", \"symptoms\", \"course\"]\n",
    "age_subtags_names = [\"median\", \"other diseases\", \"symptoms\", \"course\"]\n",
    "lower_syns = []\n",
    "for syn in custom_syns:\n",
    "    lower_syns.append([s.lower() for s in syn])\n",
    "\n",
    "    \n",
    "def get_syn(ent, orig_text, start):\n",
    "    subtag = \"None\"\n",
    "    covid_syns = [\"covid\", \"sars-cov\", \"corona\", \"ncov\", \"cov infections\"]\n",
    "    severe_syns = [\"severe\"]\n",
    "    if any(word in ent.lower() for word in covid_syns) and any(word in ent.lower() for word in severe_syns):\n",
    "        ent = \"severe covid-19\"\n",
    "    elif any(word in ent.lower() for word in covid_syns) and \"pneumonia\" in ent.lower():\n",
    "        ent = \"COVID-19 pneumonia\"\n",
    "#     elif any(word in ent.lower() for word in severe_syns):\n",
    "#         return \"severe\"\n",
    "    else:\n",
    "        for l in lower_syns:\n",
    "            if ent.lower() in l:\n",
    "                ent =  l[0]\n",
    "        \n",
    "    if ent == \"severe\":\n",
    "        for i in range(len(severe_subtags)):\n",
    "            orig_text_split = orig_text.lower().split(\" \")\n",
    "            if len(orig_text_split) > start+1 and orig_text_split[start+1] in severe_subtags[i]:\n",
    "                subtag = severe_subtags_names[i]\n",
    "                \n",
    "    if ent == \"age\":\n",
    "        if \"years\" in orig_text.lower():\n",
    "            orig_text_split = orig_text.lower().split()\n",
    "            age = \"\".join(orig_text_split[orig_text_split.index(\"age\")+1:orig_text_split.index(\"years\")])\n",
    "            regex = re.compile('[a-zA-Z]')\n",
    "            subtag = regex.sub('', age)\n",
    "        else:\n",
    "            subtag = \"concept\"\n",
    "    return ent, subtag"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Get data"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 123,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "dirs:  15%|███████████▏                                                             | 989/6459 [00:14<01:18, 69.91it/s]\n"
     ]
    },
    {
     "ename": "ValueError",
     "evalue": "'age' is not in list",
     "output_type": "error",
     "traceback": [
      "\u001b[1;31m---------------------------------------------------------------------------\u001b[0m",
      "\u001b[1;31mValueError\u001b[0m                                Traceback (most recent call last)",
      "\u001b[1;32m<ipython-input-123-e9946642a2a4>\u001b[0m in \u001b[0;36m<module>\u001b[1;34m()\u001b[0m\n\u001b[0;32m     69\u001b[0m                                 \u001b[1;32melse\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     70\u001b[0m                                     \u001b[0ment\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0msingularize\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0ment\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 71\u001b[1;33m                                     \u001b[0mnew_ent\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0msubtag\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mget_syn\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0ment\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0morig_text\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mstart\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     72\u001b[0m                                     \u001b[0minfo_tuple\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;33m(\u001b[0m\u001b[0mnew_ent\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mcl\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mneg\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mstart\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0morig_text\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0msubtag\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mtemp_sec\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mpmid\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     73\u001b[0m                                     \u001b[0mtrue_ents\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mappend\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0minfo_tuple\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;32m<ipython-input-122-1bb58132693e>\u001b[0m in \u001b[0;36mget_syn\u001b[1;34m(ent, orig_text, start)\u001b[0m\n\u001b[0;32m     65\u001b[0m         \u001b[1;32mif\u001b[0m \u001b[1;34m\"years\"\u001b[0m \u001b[1;32min\u001b[0m \u001b[0morig_text\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mlower\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m:\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     66\u001b[0m             \u001b[0morig_text_split\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0morig_text\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mlower\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msplit\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[1;32m---> 67\u001b[1;33m             \u001b[0mage\u001b[0m \u001b[1;33m=\u001b[0m \u001b[1;34m\"\"\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mjoin\u001b[0m\u001b[1;33m(\u001b[0m\u001b[0morig_text_split\u001b[0m\u001b[1;33m[\u001b[0m\u001b[0morig_text_split\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mindex\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m\"age\"\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m+\u001b[0m\u001b[1;36m1\u001b[0m\u001b[1;33m:\u001b[0m\u001b[0morig_text_split\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mindex\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m\"years\"\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m]\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0m\u001b[0;32m     68\u001b[0m             \u001b[0mregex\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mre\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0mcompile\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m'[a-zA-Z]'\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n\u001b[0;32m     69\u001b[0m             \u001b[0msubtag\u001b[0m \u001b[1;33m=\u001b[0m \u001b[0mregex\u001b[0m\u001b[1;33m.\u001b[0m\u001b[0msub\u001b[0m\u001b[1;33m(\u001b[0m\u001b[1;34m''\u001b[0m\u001b[1;33m,\u001b[0m \u001b[0mage\u001b[0m\u001b[1;33m)\u001b[0m\u001b[1;33m\u001b[0m\u001b[0m\n",
      "\u001b[1;31mValueError\u001b[0m: 'age' is not in list"
     ]
    }
   ],
   "source": [
    "\n",
    "folder = \"../LitCovid_Treatment_json/\"\n",
    "dirs = os.listdir(folder)\n",
    "pmids = []\n",
    "entities = []\n",
    "\n",
    "singulars = 0\n",
    "for file in tqdm(dirs, desc = \"dirs\"):\n",
    "# for file in dirs[:3]:\n",
    "#     try:\n",
    "    if file not in [\"exceptionlist.txt\", \"label2id.pkl\", \"predict.tf_record\"]:\n",
    "\n",
    "        #get filepath and read in data\n",
    "        file_path = os.path.join(folder, file)\n",
    "        temp = pd.read_json(file_path)\n",
    "        pmid = file[:-5]\n",
    "        section = split_sections.get(pmid)\n",
    "\n",
    "#             if section[0][0] == \"TITLE\":\n",
    "#                 sec_idx = 1\n",
    "#             else:\n",
    "#                 sec_idx = 0\n",
    "#         print(temp)\n",
    "#         print(section)\n",
    "        for i in range(temp.shape[0]):\n",
    "\n",
    "            #get entities sentence by sentence\n",
    "            ents_dict = temp.sentences.values[i].get(\"entities\")\n",
    "            orig_text = temp.sentences.values[i].get(\"text\")\n",
    "\n",
    "            if i < len(section):\n",
    "                temp_sec = section[i][0]\n",
    "#                     sec_idx +=1\n",
    "\n",
    "            else:\n",
    "                temp_sec = \"ERROR\"\n",
    "\n",
    "            if len(ents_dict.keys()) > 0:\n",
    "                temp_ents = [(ents_dict[k][\"text\"], ents_dict[k][\"class\"], ents_dict[k][\"negation\"], ents_dict[k][\"start\"], orig_text, \"None\", temp_sec, pmid) for k in ents_dict.keys()]\n",
    "                true_ents = []\n",
    "                for i in range(len(temp_ents)):\n",
    "                    ent = temp_ents[i][0]\n",
    "                    cl = temp_ents[i][1]\n",
    "                    neg = temp_ents[i][2]\n",
    "                    start = temp_ents[i][3]\n",
    "                    subtag = temp_ents[i][5]\n",
    "                    info_tuple = (new_ent, cl, neg, start, orig_text, subtag, temp_sec, pmid)\n",
    "                    added = False\n",
    "\n",
    "                    if len(ent) > 1: #make sure it's not punctuation\n",
    "\n",
    "                        if len(ent.split()) > 1: #if phrase\n",
    "\n",
    "                            #check to see if it's in custom set of synonyms\n",
    "                            new_ent, subtag = get_syn(ent, orig_text, start)\n",
    "                            info_tuple = (new_ent, cl, neg, start, orig_text, subtag, temp_sec, pmid)\n",
    "                            true_ents.append(info_tuple)\n",
    "\n",
    "                        else: #if single word\n",
    "                            if ent.lower() not in stop_words: #if not stop word\n",
    "\n",
    "                                #check to see if it's in custom set of synonyms\n",
    "                                new_ent, subtag = get_syn(ent, orig_text, start)\n",
    "\n",
    "                                if new_ent != ent:\n",
    "                                    info_tuple = (new_ent, cl, neg, start, orig_text, subtag, temp_sec, pmid)\n",
    "                                    true_ents.append(info_tuple)\n",
    "\n",
    "                                else:\n",
    "                                    ent = singularize(ent)\n",
    "                                    new_ent, subtag = get_syn(ent, orig_text, start)\n",
    "                                    info_tuple = (new_ent, cl, neg, start, orig_text, subtag, temp_sec, pmid)\n",
    "                                    true_ents.append(info_tuple)       \n",
    "\n",
    "                                    \n",
    "                entities += true_ents\n",
    "#     except:\n",
    "#         print(pmid)\n",
    "#         print(section)\n",
    "#         print(temp.sentences.values)\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<style scoped>\n",
       "    .dataframe tbody tr th:only-of-type {\n",
       "        vertical-align: middle;\n",
       "    }\n",
       "\n",
       "    .dataframe tbody tr th {\n",
       "        vertical-align: top;\n",
       "    }\n",
       "\n",
       "    .dataframe thead th {\n",
       "        text-align: right;\n",
       "    }\n",
       "</style>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>text</th>\n",
       "      <th>type</th>\n",
       "      <th>negation</th>\n",
       "      <th>start</th>\n",
       "      <th>sentence</th>\n",
       "      <th>subtag</th>\n",
       "      <th>section</th>\n",
       "      <th>pmid</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>covid-19</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>In this review , we provide an update on CoV i...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>31981224</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>relevant</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>12</td>\n",
       "      <td>In this review , we provide an update on CoV i...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>31981224</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>host defense against</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>17</td>\n",
       "      <td>In this review , we provide an update on CoV i...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>31981224</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>covid-19</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>8</td>\n",
       "      <td>This highlights the importance of immune respo...</td>\n",
       "      <td>None</td>\n",
       "      <td>CONCLUSIONS</td>\n",
       "      <td>31981224</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>covid-19</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>14</td>\n",
       "      <td>As of January 22 , 2020 , a total of 571 cases...</td>\n",
       "      <td>None</td>\n",
       "      <td>TITLE</td>\n",
       "      <td>31996494</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5</th>\n",
       "      <td>inflammation</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>Here , we propose for the first time that infl...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32013309</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6</th>\n",
       "      <td>covid-19</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>11</td>\n",
       "      <td>Here , we propose for the first time that infl...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32013309</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7</th>\n",
       "      <td>inhibited</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>13</td>\n",
       "      <td>Here , we propose for the first time that infl...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32013309</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>8</th>\n",
       "      <td>accelerate</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>accelerate its control .</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32015560</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>9</th>\n",
       "      <td>control</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>accelerate its control .</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32015560</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>10</th>\n",
       "      <td>2019-nCoV infection</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>12</td>\n",
       "      <td>As of 24 January 2020 , there were 887 confirm...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32017984</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>11</th>\n",
       "      <td>26</td>\n",
       "      <td>measure</td>\n",
       "      <td>0</td>\n",
       "      <td>16</td>\n",
       "      <td>As of 24 January 2020 , there were 887 confirm...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32017984</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>12</th>\n",
       "      <td>dead</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>17</td>\n",
       "      <td>As of 24 January 2020 , there were 887 confirm...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32017984</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>13</th>\n",
       "      <td>covid-19</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>26</td>\n",
       "      <td>Here , we focus on advances in research and de...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32017984</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>14</th>\n",
       "      <td>Persistent</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Persistent H-bonds and salt bridges were obser...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>15</th>\n",
       "      <td>H-bond</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>Persistent H-bonds and salt bridges were obser...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>16</th>\n",
       "      <td>salt bridges</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>3</td>\n",
       "      <td>Persistent H-bonds and salt bridges were obser...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>17</th>\n",
       "      <td>epitope</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>8</td>\n",
       "      <td>Persistent H-bonds and salt bridges were obser...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>18</th>\n",
       "      <td>MHC-I</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>Persistent H-bonds and salt bridges were obser...</td>\n",
       "      <td>None</td>\n",
       "      <td>BACKGROUND</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>19</th>\n",
       "      <td>2019-nCoV surface</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>21</td>\n",
       "      <td>This study took an immunoinformatics approach ...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>20</th>\n",
       "      <td>interaction</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>Also , interactions between identified CTL epi...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>21</th>\n",
       "      <td>CTL</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>Also , interactions between identified CTL epi...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>22</th>\n",
       "      <td>CTL</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>3</td>\n",
       "      <td>We identified five CTL epitopes , three sequen...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>23</th>\n",
       "      <td>sequential B</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>7</td>\n",
       "      <td>We identified five CTL epitopes , three sequen...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>24</th>\n",
       "      <td>CTL epitopes</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>6</td>\n",
       "      <td>Also , during simulations , the CTL epitopes w...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25</th>\n",
       "      <td>CTL</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>Five CTL epitopes and eight B cell epitopes we...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>26</th>\n",
       "      <td>eight</td>\n",
       "      <td>measure</td>\n",
       "      <td>0</td>\n",
       "      <td>4</td>\n",
       "      <td>Five CTL epitopes and eight B cell epitopes we...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>27</th>\n",
       "      <td>B cell</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>Five CTL epitopes and eight B cell epitopes we...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>28</th>\n",
       "      <td>Epitope-MHC-I</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>Epitope-MHC-I complexes were studied by molecu...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022276</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>29</th>\n",
       "      <td>remdesivir</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>13</td>\n",
       "      <td>Herein , we suggest four potential drug candid...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32022370</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121639</th>\n",
       "      <td>peak liver injury</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>17</td>\n",
       "      <td>In 30 % of patients with mild liver injury and...</td>\n",
       "      <td>None</td>\n",
       "      <td>OBJECTIVE</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121640</th>\n",
       "      <td>detectable</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>3</td>\n",
       "      <td>was no longer detectable in the respiratory tr...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121641</th>\n",
       "      <td>Mild liver injury</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>CONCLUSION : Mild liver injury was not associa...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121642</th>\n",
       "      <td>worse</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>CONCLUSION : Mild liver injury was not associa...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121643</th>\n",
       "      <td>outcome</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>CONCLUSION : Mild liver injury was not associa...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121644</th>\n",
       "      <td>liver impairment</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>causing liver impairment .</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121645</th>\n",
       "      <td>severe liver injury</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>Instead , severe liver injury in our cohort wa...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121646</th>\n",
       "      <td>associated</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>Instead , severe liver injury in our cohort wa...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121647</th>\n",
       "      <td>multiple-organ failure</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>Instead , severe liver injury in our cohort wa...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121648</th>\n",
       "      <td>acute vascular events</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>13</td>\n",
       "      <td>Instead , severe liver injury in our cohort wa...</td>\n",
       "      <td>None</td>\n",
       "      <td>METHODS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121649</th>\n",
       "      <td>prevalence of liver injury</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>Aim of our study was to report on the prevalen...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121650</th>\n",
       "      <td>mild vs severe liver injury</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>22</td>\n",
       "      <td>Aim of our study was to report on the prevalen...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121651</th>\n",
       "      <td>dead</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>28</td>\n",
       "      <td>Aim of our study was to report on the prevalen...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121652</th>\n",
       "      <td>covid-19</td>\n",
       "      <td>Intervention</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>COVID-19 patients and to scrutinize the tempor...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121653</th>\n",
       "      <td>liver injury</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>12</td>\n",
       "      <td>COVID-19 patients and to scrutinize the tempor...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121654</th>\n",
       "      <td>covid-19</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>11</td>\n",
       "      <td>METHODS : We present data from a German cohort...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121655</th>\n",
       "      <td>elevated</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>6</td>\n",
       "      <td>The first group included patients without elev...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121656</th>\n",
       "      <td>alanine aminotransferase or</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>7</td>\n",
       "      <td>The first group included patients without elev...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121657</th>\n",
       "      <td>bilirubin</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>10</td>\n",
       "      <td>The first group included patients without elev...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121658</th>\n",
       "      <td>acute liver failure ( ALF )</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>20</td>\n",
       "      <td>The first group included patients without elev...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121659</th>\n",
       "      <td>Liver injury</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>RESULTS : Liver injury was detected in 75 ( 50...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121660</th>\n",
       "      <td>75 ( 50.7 % )</td>\n",
       "      <td>measure</td>\n",
       "      <td>0</td>\n",
       "      <td>7</td>\n",
       "      <td>RESULTS : Liver injury was detected in 75 ( 50...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121661</th>\n",
       "      <td>93 ( 63 % )</td>\n",
       "      <td>measure</td>\n",
       "      <td>0</td>\n",
       "      <td>13</td>\n",
       "      <td>RESULTS : Liver injury was detected in 75 ( 50...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121662</th>\n",
       "      <td>ALF</td>\n",
       "      <td>Outcome</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>ALF was associated with the male sex , younger...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121663</th>\n",
       "      <td>associated</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>2</td>\n",
       "      <td>ALF was associated with the male sex , younger...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121664</th>\n",
       "      <td>male</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>5</td>\n",
       "      <td>ALF was associated with the male sex , younger...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121665</th>\n",
       "      <td>younger</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>8</td>\n",
       "      <td>ALF was associated with the male sex , younger...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121666</th>\n",
       "      <td>age</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>9</td>\n",
       "      <td>ALF was associated with the male sex , younger...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121667</th>\n",
       "      <td>higher</td>\n",
       "      <td>modifier</td>\n",
       "      <td>0</td>\n",
       "      <td>11</td>\n",
       "      <td>ALF was associated with the male sex , younger...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>121668</th>\n",
       "      <td>BMI</td>\n",
       "      <td>Participant</td>\n",
       "      <td>0</td>\n",
       "      <td>12</td>\n",
       "      <td>ALF was associated with the male sex , younger...</td>\n",
       "      <td>None</td>\n",
       "      <td>RESULTS</td>\n",
       "      <td>32777784</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>121669 rows × 8 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                               text          type  negation  start  \\\n",
       "0                          covid-19   Participant         0      9   \n",
       "1                          relevant   Participant         0     12   \n",
       "2              host defense against       Outcome         0     17   \n",
       "3                          covid-19   Participant         0      8   \n",
       "4                          covid-19   Participant         0     14   \n",
       "5                      inflammation       Outcome         0      9   \n",
       "6                          covid-19   Participant         0     11   \n",
       "7                         inhibited      modifier         0     13   \n",
       "8                        accelerate      modifier         0      0   \n",
       "9                           control       Outcome         0      2   \n",
       "10              2019-nCoV infection   Participant         0     12   \n",
       "11                               26       measure         0     16   \n",
       "12                             dead       Outcome         0     17   \n",
       "13                         covid-19       Outcome         0     26   \n",
       "14                       Persistent      modifier         0      0   \n",
       "15                           H-bond       Outcome         0      1   \n",
       "16                     salt bridges       Outcome         0      3   \n",
       "17                          epitope  Intervention         0      8   \n",
       "18                            MHC-I  Intervention         0     10   \n",
       "19                2019-nCoV surface   Participant         0     21   \n",
       "20                      interaction       Outcome         0      2   \n",
       "21                              CTL  Intervention         0      5   \n",
       "22                              CTL       Outcome         0      3   \n",
       "23                     sequential B       Outcome         0      7   \n",
       "24                     CTL epitopes  Intervention         0      6   \n",
       "25                              CTL       Outcome         0      1   \n",
       "26                            eight       measure         0      4   \n",
       "27                           B cell       Outcome         0      5   \n",
       "28                    Epitope-MHC-I       Outcome         0      0   \n",
       "29                       remdesivir  Intervention         0     13   \n",
       "...                             ...           ...       ...    ...   \n",
       "121639            peak liver injury       Outcome         0     17   \n",
       "121640                   detectable      modifier         0      3   \n",
       "121641            Mild liver injury   Participant         0      2   \n",
       "121642                        worse      modifier         0      9   \n",
       "121643                      outcome       Outcome         0     10   \n",
       "121644             liver impairment       Outcome         0      1   \n",
       "121645          severe liver injury       Outcome         0      2   \n",
       "121646                   associated      modifier         0      9   \n",
       "121647       multiple-organ failure       Outcome         0     10   \n",
       "121648        acute vascular events       Outcome         0     13   \n",
       "121649   prevalence of liver injury       Outcome         0      9   \n",
       "121650  mild vs severe liver injury  Intervention         0     22   \n",
       "121651                         dead       Outcome         0     28   \n",
       "121652                     covid-19  Intervention         0      0   \n",
       "121653                 liver injury       Outcome         0     12   \n",
       "121654                     covid-19   Participant         0     11   \n",
       "121655                     elevated   Participant         0      6   \n",
       "121656  alanine aminotransferase or   Participant         0      7   \n",
       "121657                    bilirubin   Participant         0     10   \n",
       "121658  acute liver failure ( ALF )   Participant         0     20   \n",
       "121659                 Liver injury       Outcome         0      2   \n",
       "121660                75 ( 50.7 % )       measure         0      7   \n",
       "121661                  93 ( 63 % )       measure         0     13   \n",
       "121662                          ALF       Outcome         0      0   \n",
       "121663                   associated      modifier         0      2   \n",
       "121664                         male   Participant         0      5   \n",
       "121665                      younger      modifier         0      8   \n",
       "121666                          age   Participant         0      9   \n",
       "121667                       higher      modifier         0     11   \n",
       "121668                          BMI   Participant         0     12   \n",
       "\n",
       "                                                 sentence subtag      section  \\\n",
       "0       In this review , we provide an update on CoV i...   None   BACKGROUND   \n",
       "1       In this review , we provide an update on CoV i...   None   BACKGROUND   \n",
       "2       In this review , we provide an update on CoV i...   None   BACKGROUND   \n",
       "3       This highlights the importance of immune respo...   None  CONCLUSIONS   \n",
       "4       As of January 22 , 2020 , a total of 571 cases...   None        TITLE   \n",
       "5       Here , we propose for the first time that infl...   None      RESULTS   \n",
       "6       Here , we propose for the first time that infl...   None      RESULTS   \n",
       "7       Here , we propose for the first time that infl...   None      RESULTS   \n",
       "8                                accelerate its control .   None   BACKGROUND   \n",
       "9                                accelerate its control .   None   BACKGROUND   \n",
       "10      As of 24 January 2020 , there were 887 confirm...   None   BACKGROUND   \n",
       "11      As of 24 January 2020 , there were 887 confirm...   None   BACKGROUND   \n",
       "12      As of 24 January 2020 , there were 887 confirm...   None   BACKGROUND   \n",
       "13      Here , we focus on advances in research and de...   None   BACKGROUND   \n",
       "14      Persistent H-bonds and salt bridges were obser...   None   BACKGROUND   \n",
       "15      Persistent H-bonds and salt bridges were obser...   None   BACKGROUND   \n",
       "16      Persistent H-bonds and salt bridges were obser...   None   BACKGROUND   \n",
       "17      Persistent H-bonds and salt bridges were obser...   None   BACKGROUND   \n",
       "18      Persistent H-bonds and salt bridges were obser...   None   BACKGROUND   \n",
       "19      This study took an immunoinformatics approach ...   None      RESULTS   \n",
       "20      Also , interactions between identified CTL epi...   None      RESULTS   \n",
       "21      Also , interactions between identified CTL epi...   None      RESULTS   \n",
       "22      We identified five CTL epitopes , three sequen...   None      RESULTS   \n",
       "23      We identified five CTL epitopes , three sequen...   None      RESULTS   \n",
       "24      Also , during simulations , the CTL epitopes w...   None      RESULTS   \n",
       "25      Five CTL epitopes and eight B cell epitopes we...   None      RESULTS   \n",
       "26      Five CTL epitopes and eight B cell epitopes we...   None      RESULTS   \n",
       "27      Five CTL epitopes and eight B cell epitopes we...   None      RESULTS   \n",
       "28      Epitope-MHC-I complexes were studied by molecu...   None      RESULTS   \n",
       "29      Herein , we suggest four potential drug candid...   None      RESULTS   \n",
       "...                                                   ...    ...          ...   \n",
       "121639  In 30 % of patients with mild liver injury and...   None    OBJECTIVE   \n",
       "121640  was no longer detectable in the respiratory tr...   None      METHODS   \n",
       "121641  CONCLUSION : Mild liver injury was not associa...   None      METHODS   \n",
       "121642  CONCLUSION : Mild liver injury was not associa...   None      METHODS   \n",
       "121643  CONCLUSION : Mild liver injury was not associa...   None      METHODS   \n",
       "121644                         causing liver impairment .   None      METHODS   \n",
       "121645  Instead , severe liver injury in our cohort wa...   None      METHODS   \n",
       "121646  Instead , severe liver injury in our cohort wa...   None      METHODS   \n",
       "121647  Instead , severe liver injury in our cohort wa...   None      METHODS   \n",
       "121648  Instead , severe liver injury in our cohort wa...   None      METHODS   \n",
       "121649  Aim of our study was to report on the prevalen...   None      RESULTS   \n",
       "121650  Aim of our study was to report on the prevalen...   None      RESULTS   \n",
       "121651  Aim of our study was to report on the prevalen...   None      RESULTS   \n",
       "121652  COVID-19 patients and to scrutinize the tempor...   None      RESULTS   \n",
       "121653  COVID-19 patients and to scrutinize the tempor...   None      RESULTS   \n",
       "121654  METHODS : We present data from a German cohort...   None      RESULTS   \n",
       "121655  The first group included patients without elev...   None      RESULTS   \n",
       "121656  The first group included patients without elev...   None      RESULTS   \n",
       "121657  The first group included patients without elev...   None      RESULTS   \n",
       "121658  The first group included patients without elev...   None      RESULTS   \n",
       "121659  RESULTS : Liver injury was detected in 75 ( 50...   None      RESULTS   \n",
       "121660  RESULTS : Liver injury was detected in 75 ( 50...   None      RESULTS   \n",
       "121661  RESULTS : Liver injury was detected in 75 ( 50...   None      RESULTS   \n",
       "121662  ALF was associated with the male sex , younger...   None      RESULTS   \n",
       "121663  ALF was associated with the male sex , younger...   None      RESULTS   \n",
       "121664  ALF was associated with the male sex , younger...   None      RESULTS   \n",
       "121665  ALF was associated with the male sex , younger...   None      RESULTS   \n",
       "121666  ALF was associated with the male sex , younger...   None      RESULTS   \n",
       "121667  ALF was associated with the male sex , younger...   None      RESULTS   \n",
       "121668  ALF was associated with the male sex , younger...   None      RESULTS   \n",
       "\n",
       "            pmid  \n",
       "0       31981224  \n",
       "1       31981224  \n",
       "2       31981224  \n",
       "3       31981224  \n",
       "4       31996494  \n",
       "5       32013309  \n",
       "6       32013309  \n",
       "7       32013309  \n",
       "8       32015560  \n",
       "9       32015560  \n",
       "10      32017984  \n",
       "11      32017984  \n",
       "12      32017984  \n",
       "13      32017984  \n",
       "14      32022276  \n",
       "15      32022276  \n",
       "16      32022276  \n",
       "17      32022276  \n",
       "18      32022276  \n",
       "19      32022276  \n",
       "20      32022276  \n",
       "21      32022276  \n",
       "22      32022276  \n",
       "23      32022276  \n",
       "24      32022276  \n",
       "25      32022276  \n",
       "26      32022276  \n",
       "27      32022276  \n",
       "28      32022276  \n",
       "29      32022370  \n",
       "...          ...  \n",
       "121639  32777784  \n",
       "121640  32777784  \n",
       "121641  32777784  \n",
       "121642  32777784  \n",
       "121643  32777784  \n",
       "121644  32777784  \n",
       "121645  32777784  \n",
       "121646  32777784  \n",
       "121647  32777784  \n",
       "121648  32777784  \n",
       "121649  32777784  \n",
       "121650  32777784  \n",
       "121651  32777784  \n",
       "121652  32777784  \n",
       "121653  32777784  \n",
       "121654  32777784  \n",
       "121655  32777784  \n",
       "121656  32777784  \n",
       "121657  32777784  \n",
       "121658  32777784  \n",
       "121659  32777784  \n",
       "121660  32777784  \n",
       "121661  32777784  \n",
       "121662  32777784  \n",
       "121663  32777784  \n",
       "121664  32777784  \n",
       "121665  32777784  \n",
       "121666  32777784  \n",
       "121667  32777784  \n",
       "121668  32777784  \n",
       "\n",
       "[121669 rows x 8 columns]"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ent_df = pd.DataFrame(entities, columns=[\"text\", \"type\", \"negation\", \"start\", \"sentence\", \"subtag\", \"section\", \"pmid\"])\n",
    "# ent_df.to_csv(\"LitCovid_treatment_ents.csv\")\n",
    "ent_df\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "521\n",
      "195\n"
     ]
    }
   ],
   "source": [
    "print(ent_df[(ent_df.text == \"severe\")].shape[0])\n",
    "print(ent_df[(ent_df.text == \"severe\") & (ent_df.subtag == \"None\")].shape[0])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 67,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array(['For cases of severe illness , early and also short periods of moderate glucocorticoid was supported .',\n",
       "       'According to the relevant diagnostic criteria , the patients were divided into three groups : mild ( 15 cases ) , severe ( 9 cases ) and critical ( 5',\n",
       "       'Severe or critically ill COVID-19 patients with myocardial injury face a significantly higher risk of in-hospital mortality .',\n",
       "       'Compared to the mild cases , the severe ones had lower lymphocyte counts and higher plasma levels of Pt , APTT , d-dimer , lactate dehydrogenase , PCT , ALB',\n",
       "       'Acute respiratory distress syndrome ( ARDS ) was the most severe pulmonary complication that caused high mortality rate .',\n",
       "       'Among them , two common and one severe patient were recovered and discharged in 10 days after treatment .',\n",
       "       'The symptoms in neonates were milder and outcomes were less severe compared to adults .',\n",
       "       'subjects , 2 with light , common or severe subjects , 1 with light and common subjects , 1 with common or severe subjects , 3 with severe subjects ,',\n",
       "       'them became severe .',\n",
       "       'Preliminary evidence suggests children are just as likely as adults to become infected with SARS-CoV-2 but are less likely to be symptomatic or develop severe symptoms .',\n",
       "       'With a median ( IQR ) follow-up time of 24.0 ( 17.5-30.0 ) days , progression occurred in 19.6 % moderate , 27.8 % severe and 66.7 % critical COVID-19',\n",
       "       'the management of severely ill patients with COVID-19 who develop acute respiratory and cardiac compromise refractory to conventional therapy .',\n",
       "       'In particular , all 8 of the DIP-treated severely ill patients showed remarkable improvement : 7 patients ( 87.5 % ) achieved clinical cure and were discharged from the hospitals',\n",
       "       'SARS-CoV-2-positive patients were classified as having mild ( n = 30 ) , severe ( n = 20 ) , and extremely severe ( n = 15 ) illness .',\n",
       "       'MAIN RESULTS : We identified 33 studies reporting 385 pregnant women with COVID-19 infection : 368 ( 95.6 % ) mild ; 14 ( 3.6 % ) severe ; and',\n",
       "       'Infants and young children had relatively more severe illness than older children .',\n",
       "       'Disease severity and clinical course characteristics of the patients and influencing factors of severe illness were analyzed in our study .',\n",
       "       'Methods : A retrospective case analysis of effectiveness and safety of aliskiren treatment to lower blood pressure in three severe and one critically ill patients of COVID-19 with hypertension .',\n",
       "       'Three cases were confirmed by 2019-nCoV nucleic acid and antibody detection ( severe type ) , and one with cardiac insufficiency was clinically determined ( critically ill type ) .',\n",
       "       'Compared with non-severely ill patients , severely ill patients were older ( mean , years , 52.8 vs. 45.3 , p < 0.01 ) , had a higher proportion of',\n",
       "       'Of the 43 severely ill patients , 6 ( 14 % ) received high-flow nasal cannula oxygen therapy , and 1 ( 2.3 % ) received invasive mechanical ventilation .',\n",
       "       'Outcomes of severely ill patients and non-severely ill patients were compared .',\n",
       "       'All patients were divided into severe ( 69 ) and non-severe group ( 135 ) .',\n",
       "       'In this retrospective study , we evaluated the levels of a series of serum biomarkers in coronavirus disease 2019 ( COVID-19 ) patients ( mild : 131 ; severe :',\n",
       "       'The differences in the hemocyte counts and dynamic profiles in patients with severe and non-severe COVID-19 were compared .',\n",
       "       '( 24.6 % ) had severe illness .',\n",
       "       'Forty-eight cytokines in the plasma samples from 50 COVID-19 cases including 11 critically ill , 25 severe , and 14 moderate patients were measured and analyzed in combination with clinical',\n",
       "       'shown to be highly associated with disease severity during disease progression , were remarkably higher in critically ill patients , followed by severe and then the moderate patients .',\n",
       "       'applied in severely ill patients to reduce pneumonia related mortality .',\n",
       "       'The included patients were classified into mild ( n = 168 ) , severe ( n = 169 ) and critical groups ( n = 52 ) .',\n",
       "       'applied for prophylaxis , for early phases of illness , and for severe illness .',\n",
       "       'Only one of the most severely ill patients scored > = 2 on the quick Sepsis-related Organ Failure Assessment ( qSOFA ) on admission .',\n",
       "       'Hydroxychloroquine-treated patients were more severely ill at baseline than those who did not receive hydroxychloroquine ( median ratio of partial pressure of arterial oxygen to the fraction of inspired oxygen',\n",
       "       'Severe illness was associated with lower lymphocyte and higher leukocyte counts .',\n",
       "       '23 ( 11.4 % ) patients had severe illness .',\n",
       "       'This study aimed to describe the clinical characteristics of COVID-19 and identify the risk factors for severe illness of COVID-19 in Jiangsu province , China .',\n",
       "       'Clinical findings of COVID-19 patients were described and risk factors for severe illness of COVID-19 were analyzed .',\n",
       "       'Covid-19 is characterized by weak symptoms in most affected patients whilst severe clinical complications , with frequent fatal issues , occur in others .',\n",
       "       'presented with more severe forms ( higher level of oxygen therapy at 13 L/min vs 6 L/min , P < 0.001 ) , and had poorer biological findings ( severe',\n",
       "       'severe illness and of course before full-blown ARDS ( Acute Respiratory Distress Syndrome ) .',\n",
       "       'Of 64 pregnant women hospitalized with COVID-19 , 44 ( 69 % ) had severe and 20 ( 31 % ) critical disease .',\n",
       "       'The median duration of hospital stay was 6 days ( 6 days for severe , 10.5 days for critical , p=0.01 ) .',\n",
       "       'Thirty-two ( 50 % ) women in this cohort delivered during their COVID-19 hospitalization ( 34 % of severe and 85 % of critical women ) .',\n",
       "       '6 severe versus 12 critical ) .',\n",
       "       'For cases of severe illness , early and also short period of moderate glucocorticoid was supported .',\n",
       "       'RESULTS : One patient in HCQ group developed to severe during the treatment .',\n",
       "       'Conclusions and Relevance : This early report describes the burden of COVID-19 infection in North American PICUs and confirms that severe illness in children is significant but far less frequent',\n",
       "       'RESULTS : Patients with cardiovascular disease were at greater risk of developing COVID-19 , especially in its severe form .',\n",
       "       'moderately ill , severely ill , and critically ill , respectively .',\n",
       "       'Studies were divided into 2 separate cohorts for analysis : severity ( severe vs nonsevere ) and mortality ( nonsurvivors vs survivors ) .',\n",
       "       'A higher proportion of newborns was severely ill ( 12 % ) and dyspnea was the most common reported sign ( 40 % ) .',\n",
       "       'The resultant cytokine storm is responsible for the severe lung injury leading to acute respiratory distress syndrome seen in COVID 19 patients .',\n",
       "       'However , lymphopenia was more severe in males than females and levels of tumor necrosis factor alpha were reduced significantly in critical cases than severe and mild cases .',\n",
       "       'Severity of disease : 5.3 % light and common type , 17.6 % severe and critically ill and 59.6 % with no restricted classification .',\n",
       "       'METHODS : Sixty-nine patients with COVID-19 were classified into severe and nonsevere groups to analyze their clinical and laboratory characteristics .',\n",
       "       '; severe : 167 ( 138 , 197 ) ; critical : 125 ( 95 , 162 ) ; P < .05 ) across all three groups .',\n",
       "       'As recently reported , the cumulative risk of the composite end-point was 3.6 % in all COVID-19 patients , and the cumulative risk was 20.6 % for severe illness [',\n",
       "       'care for severely ill COVID-19 patients , including stratification , isolation , and affordable diagnostic approaches and supportive care measures .',\n",
       "       'Current evidence suggests an important role of interleukin-6 ( IL-6 ) pathway in SARS-CoV-2-related cytokine release storm in severely ill COVID-19 patients .',\n",
       "       'Patients with comorbidities are more likely to develop severe illness .',\n",
       "       'Three patients with comorbidities such as hypertension , liver diseases or diabetes developed severe illness .',\n",
       "       'High C-reactive protein levels and elevations of both ALT and AST were observed in 3 severely ill patients on admission .',\n",
       "       'Patients were classified into four groups , mild , moderate , severe and critically ill .',\n",
       "       'Thirty percent of our patients had severe or critically ill disease , but only 20 % of severe and 33 % of critically ill patients had been to Wuhan .',\n",
       "       'Conclusions Dynamic changes in vital hematological parameters from severe and non-severe patients had been characterized in the course of hospitalization .',\n",
       "       'We have measured Hb O2 affinity curves from severely ill COVID-19 patients and , in comparison to age- and sex-matched controls , find no evidence for a shift in O2',\n",
       "       'Early reports suggest a high incidence of VTE in hospitalized COVID-19 patients , particularly those with severe illness , that is similar to the high VTE rates observed in patients',\n",
       "       'Receiver operating characteristic analysis distinguished severe and nonsevere patients according to KL-6 serum levels and the best cut-off value was 406.5 U/mL .',\n",
       "       'severe illness .',\n",
       "       'ALT was between two and five times ULN , and severe if ALT was > five times ULN .',\n",
       "       'Here we characterise the outcomes of a cohort of patients with cancer and COVID-19 and identify potential prognostic factors for mortality and severe illness .',\n",
       "       '42 consecutive pregnancies were recruited and classified into two groups : severe and nonsevere COVID-19 , according to the occurrence of severe pneumonia .',\n",
       "       'COVID-19 is especially severe for elderly subjects with cardiometabolic and respiratory comorbidities .',\n",
       "       'A higher frequency seems to be present in severely ill patients , in particular those admitted to intensive care units .',\n",
       "       'The trial included 103 participants with laboratory-confirmed COVID-19 that was severe ( respiratory distress and/or hypoxemia ) or life-threatening ( shock , organ failure , or requiring mechanical ventilation )',\n",
       "       'Therefore , we compared cell-mediated immune ( CMI ) responses between severe and mild COVID-19 cases .',\n",
       "       'Those with concomitant infections had more severe illness .',\n",
       "       'CONCLUSION : Together , our data suggest that early intervention to increase expression of CCL5 may prevent patients from developing severe illness .',\n",
       "       'The author mentioned that COVID-19 appeared to be milder in children than in adults but said there was a knowledge gap about antiviral treatment in severely ill patients .',\n",
       "       'A total of 54 patients were enrolled and divided into three groups , among which 34 were common , 14 were severe , and 6 were critical .',\n",
       "       'Peripheral blood from 18 SARS-CoV-2-infected patients , 9 with severe and 9 with mild COVID-19 disease , was obtained at admission and analyzed for T-cell activation profile , myeloid-derived suppressor',\n",
       "       'In four severe and in four mild patients , a longitudinal analysis was performed daily from the day of admission to the early convalescent phase .',\n",
       "       'Globally , 14 patients ( 20.3 % ) presented a mild , 30 ( 43.5 % ) a severe and 25 ( 36.2 % ) a critical COVID-19 disease .',\n",
       "       '21 ( 16.0 % ) severely ill patients and 5 ( 3.8 % ) individuals with life-threatening conditions .',\n",
       "       'The majority ( 97.8 % ) of infected children were not severe , and 24 ( 13.2 % ) of them had asymptomatic infections .',\n",
       "       'Patients with severe illness are found to have a higher cardio- cerebrovascular comorbidity .',\n",
       "       'Systemic immune over activation due to SARS-CoV-2 infection causes the cytokine storm , which is especially noteworthy in severely ill patients with COVID-19 .',\n",
       "       ', 78 ( 11.9 % ) , and 276 ( 42.1 % ) of the 655 patients , respectively , were significantly enriched among patients classified as severe .',\n",
       "       'Severe morbidity and mortality among women with MERS-CoV , SARS-CoV , or SARS-CoV-2 infection in pregnancy and adverse pregnancy outcomes , including pregnancy loss , preterm delivery , and laboratory',\n",
       "       'The clinical presentations were not as severe as the signs observed in the computed tomography ( CT ) images , and the recovery of lesions in lobules lagged behind that',\n",
       "       'SARS was characterized by severe lung injury due to virus-induced cytopathic effects and dysregulated hyperinflammatory state .',\n",
       "       'The incidences of AKI were compared between severe versus non-severe patients and survivors versus non-survivors .',\n",
       "       'Throughout the delivery hospitalization , 26.5 % of women met World Health Organization criteria for mild COVID-19 , 26.1 % for severe , and 5 % for critical .',\n",
       "       'Cesarean birth was the mode of delivery for 52.4 % of women with severe and 91.7 % with critical COVID-19 .',\n",
       "       'The results show that 27 ( 33.8 % ) patients had severe illness .',\n",
       "       'Treatment recommendations address 2 phases of hospitalization : when patients are critically ill and admitted to the intensive care unit , and when patients are severely ill and admitted to',\n",
       "       'Epidemiology studies found males although only slightly more likely to be infected than females account for the majority of the severely ill and fatality , which also bias for people',\n",
       "       'In conclusion , intensification of heparin treatment should be considered in the context of COVID-19 on the basis of clinical and biological criteria of severity , especially in severely ill',\n",
       "       'COVID-19 was severe in patients with lung cancer ( 62 % hospitalized , 25 % died ) .',\n",
       "       'Of the 54 patients ( 56.1 +- 13.5 years old , 66.7 % male ) with COVID-19 , 39 were diagnosed as severe and 15 as critical cases .',\n",
       "       'present a Perspective on diverse immunotherapeutic approaches based on the neutralization of inflammatory cytokines , immunomodulation , and passive viral neutralization for treating severely ill COVID-19 patients .',\n",
       "       'In addition , microcomputed tomographic imaging revealed severe lung injury that shared characteristics with SARS-CoV-2-infected human lung , including severe , bilateral , peripherally distributed , multilobular ground glass opacity',\n",
       "       'Hypertension was more prevalent in severe [ 47.65 % ( 95 % CI : 35.04 % , 60.26 % ) ] and fatal [ 47.90 % ( 95 % CI',\n",
       "       'A difference in C-reactive protein levels between severe and critical groups was also found ( P < 0.05 ) .',\n",
       "       'Results : A total of 114 COVID-19 patients ( 99 mild , 4 severe , 11 critical ) of which 56 ( 56/114 ; 49.1 % ) were male ,',\n",
       "       'Interpretation : This is the first systematic review exploring the risk factors for severe illness in COVID-19 patients .',\n",
       "       'The typical CT imaging features were as follows : the ordinary type mainly showed the single or multiple ground glass shadows on the chest image ; the severe type mainly',\n",
       "       'The patients were divided into mild , ordinary , severe and critical types .',\n",
       "       '23 % , moderate 38 % , extensive 22 % , and severe 7 % ) .',\n",
       "       'A total of 185 patients were included , 27 ( 14.59 % ) of whom were severely ill at the time of discharge and three ( 1.6 % ) of',\n",
       "       'In our view , targeting host-mediated immunopathology holds promise to alleviate progressive pathologic complications of ARDS and reduce morbidities and mortalities in severely ill patients with COVID-19 .',\n",
       "       \"Methods : We assembled a retrospective cohort of 80 patients ( including 56 mild and 24 severe ) with COVID-19 infection treated at Beijing You'an Hospital .\",\n",
       "       'The production and sialylation of AAT increased in COVID-19 , but this antiinflammatory response was overwhelmed in severe illness , with the IL-6 : AAT ratio markedly higher in patients',\n",
       "       'Secondary Endpoints : The patients are classified according to their oxygen levels as mild , moderate and severe and randomized according to their classification to the intervention and control in',\n",
       "       'This study aimed to determine the differences between laboratory parameters in ( 1 ) COVID-19 versus non-COVID-19 pneumonia , and ( 2 ) severe versus non-severe COVID-19 cases .',\n",
       "       'Severe Covid-19 occurs in the presence of impaired glucose metabolism in patients , including those with DM , PreDM and obesity .',\n",
       "       'The proportions of third-generation patients developing severe illness ( 72.7 % vs. 32.5 % and 27.3 % , p < 0.001 ) , critical illness ( 38.6 % vs. 10.8',\n",
       "       'Literature and experience from healthcare teams in the midst of the pandemic suggest that any COVID-19 patients with respiratory compromise severe enough to warrant admission should be considered for proning',\n",
       "       'Overall , 13.0 % ( 954 of 7,341 ) of the cases were severe .',\n",
       "       'Severe COVID-19 occurred despite suppressive antiretroviral therapy in this cohort .',\n",
       "       'Patients over the age of 60 were the ones having severe illness and more complications ( p < 0.05 ) .',\n",
       "       'severe and have a worse outcome than those without ( OR=2.31 , 95 % CI [ 1.3-4.12 ] ) .',\n",
       "       'Lymphopenia is severe and constant , with a nadir on day 2 of ICU stay ( median 0.555 109/L ; interquartile range ( IQR ) 0.450 109/L ) ; all',\n",
       "       'A total of 48 cases of COVID-19 were collected , of which 1 was mild , 38 were moderate , and 9 were severe .',\n",
       "       'seen in other severe pathogenic infections .',\n",
       "       'The severe and critically severe groups had elevated levels of white blood cells ( WBC ) , neutrophils , platelets , C-reaction protein ( CRP ) , lymphocyte ratio (',\n",
       "       'We conclude DKA is common and severe in individuals hospitalised with COVID-19 .',\n",
       "       ') patients belonged to the stable group , another 10 patients were severe before admission .',\n",
       "       'The differences between moderate ( 29.00 [ 25.75-37.50 ] ) and severe ( 43.00 [ 38.75-47.25 ] ) ( p = 0.022 ) or between moderate and critical ( 47.50',\n",
       "       'The cohort included 400 ( 66.89 % ) moderate cases , 85 ( 14.21 % ) severe and 113 ( 18.90 % ) critical cases , of whom 79 died',\n",
       "       'The degree of severity of COVID-19 patients ( severe vs. non-severe ) was defined at the time of admission according to American Thoracic Society guidelines for community acquired pneumonia .',\n",
       "       'Two groups of patients with RT-PCR-confirmed COVID-19 were enrolled in this study : 12 severely ill patients in intensive care units who needed mechanical ventilation and 11 mildly ill patients',\n",
       "       'Results showed that most of the severely ill patients had viral shedding in a variety of tissues for 20-40 days after onset of disease ( 8/12 , 66.7 % )',\n",
       "       'Twenty-seven patients ( 36.5 % ) were severe and 10 patients ( 13.5 % ) died .',\n",
       "       'All patients had suffered from severe ( 5/9 ) or moderate ( 4/9 ) acute respiratory distress syndrome , requiring prolonged stay in the intensive care unit .',\n",
       "       'All patients were local residents of Wuhan , and a large proportion of them were diagnosed with severe illness when admitted .',\n",
       "       'Meanwhile , we monitored the serum lipid profile , COVID-19 nucleic acid and chest CT scan of a severe patient from the early stage of infection to the recovery period',\n",
       "       'Obesity is an independent risk factor for severe illness in COVID-19 .',\n",
       "       'Random effects meta-analysis was done to estimate standard mean difference ( SMD ) of NLR and PLR values with 95 % confidence interval ( CI ) between severe and non-severe',\n",
       "       'Nineteen studies reported NLR values , while five studies reported PLR values between severe and non-severe COVID-19 patients .',\n",
       "       'A total of 76 patients developed liver injury ( mild , 40.5 % ; moderate , 15.3 % ; severe , 2.3 % ) with a median occurrence time of',\n",
       "       'of severe illness than ARB users .',\n",
       "       'significantly higher than in those with severe ( 20 [ 14 % ] of 145 ) or moderate ( nine [ 6 % ] of 149 ) disease ( p',\n",
       "       'Elder age , increased number of affected lobes , higher levels of serum CRP , chest tightness/dyspnea , and smoking history were risk factors for mortality of severe COVID-19 patients',\n",
       "       'According to the disease severity , the patients were categorized as three groups ( moderate : 85 , severe : 54 , and critical : 20 ) .',\n",
       "       'Then , patients were divided into two groups : nonsevere ( moderate ) and severe ( severe and critical ) .',\n",
       "       'Severe bleeding events were described in severe ARDS patients requiring ECMO in large cohorts [ 2 ] .',\n",
       "       'In addition , CD3+ CD8+ T lymphocytes , CD16+ CD56+ NK cells , and complement C1q in severely ill patients decreased more significantly .',\n",
       "       'The mortality rate of severely ill patients in the early stage is 32.5 % .',\n",
       "       'This study analyzed clinical and biochemical parameters between mild and severe patients , helping to identify severe or critical patients early .',\n",
       "       'Results : Sixty studies comparing 5487 subjects with severe and 9670 subjects with mild COVID-19 documented higher PT ( SMD : 0.41 ; 95 % CI : 0.21 , 0.60',\n",
       "       'Patients aged under 18 years had higher re-positive rates than average , and none of the severely ill patients re-tested positive .',\n",
       "       'Headache , dizziness , taste and smell dysfunctions , and impaired consciousness were the most frequently described neurological symptoms , the latter more often among patients with a severe or',\n",
       "       'In vitro , ViroSAL inhibited the enveloped viruses Epstein-Barr , measles , herpes simplex , Zika and orf parapoxvirus , together with Ebola , Lassa , vesicular stomatitis and severe',\n",
       "       'Significant differences were observed when comparing severe and non-severe patients .',\n",
       "       'Studies were included in our meta-analysis if it was published in peer-reviewed journals and recorded patient characteristics of severe versus nonsevere or survivor versus nonsurvivor in coronavirus disease 2019 infection',\n",
       "       'Further analysis showed that decreases in lymphocytes , total proteins , and SOD and elevations in neutrophils , FDP , CRP , and ESR were more common in severe than',\n",
       "       'Six ( 14.6 % ) patients died ( severe : 2 , critical : 4 ) ; high creatinine with low lymphocyte count was the biggest challenge of immunosuppression management',\n",
       "       'Patients were classified into three catalogs according to severity of pneumonia : 17 ( 41.5 % ) were mild , 15 ( 36.6 % ) severe , and 9 (',\n",
       "       'In this comparative analysis , by day 14 , remdesivir was associated with significantly greater recovery and 62 % reduced odds of death versus standard-of-care treatment in patients with severe',\n",
       "       'We also analyzed whether the use of these drugs affects the risk of SARS-CoV-2 infection , severe illness or mortality based on recent studies .',\n",
       "       'Previously , there were two outbreaks of severe coronavirus caused by different coronaviruses worldwide , namely Severe Acute Respiratory Syndrome Coronavirus ( SARS-CoV ) and the Middle East Respiratory Syndrome',\n",
       "       'Median IgG and IgM levels in acute and convalescent-phase sera ( within 35 days ) for all included patients were calculated and compared between severe and non-severe patients .',\n",
       "       'Particularly , immunomodulatory mechanisms employed by the placenta may mitigate violent immune response , maybe soften cytokine storm tightly associated with severely ill COVID-19 patients , possibly minimizing cell and',\n",
       "       '61.3 % were severe , and 38.7 % were mild .',\n",
       "       'The overall outcome was severe , with high frequencies of hospitalisation ( 69.8 % ) , respiratory support oxygen ( 55.7 % ) , non-invasive ventilation ( 20.9 % )',\n",
       "       'Secondary bacterial infection was detected in 41 % of critical cases , but none of the severe ones .',\n",
       "       'Disease course of the patients was grouped as severe or critical , according to their clinical , laboratory and radiologic evaluations .',\n",
       "       'Of the 891 cases , 582 were severe or critical , including 423 ( 73 % ) severe and 159 ( 27 % ) critical cases .',\n",
       "       'Of the 891 cases , 582 were severe or critical , including 423 ( 73 % ) severe and 159 ( 27 % ) critical cases .',\n",
       "       'in the management of severely ill COVID-19 patients .',\n",
       "       'severe illness .',\n",
       "       'Overweight and obesity were independent risk factors of severe illness in COVID-19 patients .',\n",
       "       'Two hundred and sixty-one patients ( 22 % ) developed a severe illness after admission .',\n",
       "       'sNox2-dp values were higher in Covid-19 patients versus controls and in severe versus non severe Covid-19 .',\n",
       "       'Their mean age was 47.8 years , 43 ( 67.2 % ) cases were non-severe , 21 ( 32.8 % ) were severe , and 2 patients ( 3.1 %',\n",
       "       'Patients with co-morbidities such as hypertension , cardiovascular disease , and diabetes mellitus ( DM ) seem to be more prone to severe symptoms and appear to have a higher',\n",
       "       'This review aims to assess the risk of drug-drug interactions in the severely ill COVID-19 patient .',\n",
       "       'Increases in the level of serum liver enzymes , D-dimer , cardiac troponin I , and creatinine have been observed in severely ill patients , indicating that multiple organ failure',\n",
       "       '% ) were severe or required ICU care .',\n",
       "       'During the follow-up , 30 % vs. 31.4 % in HBV group vs. non-HBV group progressed to severe COVID-19 ( p=0.97 ) .',\n",
       "       'CONCLUSIONS : Severe or critically ill patients with COVID-19 is about one-tenths of patients in Jiangsu .',\n",
       "       'There was a significant older age among severe ( 62.6 years old +-10.1SD ) than mild to moderate infection ( 55.5 +- 10.1 ) ( p 0.05 ) .',\n",
       "       'Importantly , three patients , one severe and two critical ill type , with increased D-dimer survived after anticoagulant therapy with continuous heparin infusion .',\n",
       "       'severe or progression toward severe COVID-19 .',\n",
       "       ', severe ( n = 7 ) , and critical ( n = 2 ) .',\n",
       "       'n = 18 ) , and continuously severe or critical ( n = 9 ) .',\n",
       "       'We then focused on investigating the differences in the epidemiological and laboratory indicators between remained stable cases and progressed to severe condition cases .',\n",
       "       'No differences were observed of antibody levels between severe and non-severe patients .',\n",
       "       'Younger infants and those with comorbidity were found to be at risk of severe illness .',\n",
       "       'Fifty-four PLWH developed COVID-19 with 14 severe ( 25.9 % ) and five critical cases ( 9.3 % ) , respectively .',\n",
       "       'n = 1 ) , severe ( n = 2 ) , and critical ( n = 1 ) involvement .',\n",
       "       'RESULTS : All 35 patients were diagnosed as having mild-to-moderate COVID-19 at admission , but the severity aggravated to severe in 8 patients ( 22.9 % ) in hospital .',\n",
       "       'Similar trends were observed comparing severe to non-severe groups .',\n",
       "       'In this study we examined hospitalized kidney transplant recipients with non-severe ( n = 21 ) and severe ( n =19 ) COVID-19 .'],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 67,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "ent_df[(ent_df.text == \"severe\") & (ent_df.subtag == \"None\")].sentence.values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 140,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([{'Section': 'METHODS', 'text': 'Coronavirus can cause respiratory syndrome which to date has affected about twelve thousand individuals , especially in China .', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': 'Coronavirus is interspecies and can also be transmitted from man to man , with an incubation ranging from 1 to 14 days .', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': 'Human coronavirus infections can induce not only mild to severe respiratory diseases , but also inflammation , high fever , cough , acute respiratory tract infection and dysfunction of internal', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': 'organs that may lead to death .', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': 'Coronavirus infection ( regardless of the various types of corona virus ) is primarily attacked by immune cells including mast cells ( MCs ) , which are located in the', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': 'submucosa of the respiratory tract and in the nasal cavity and represent a barrier of protection against microorganisms .', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': 'Viral activate MCs release early inflammatory chemical copounds including histamine and protease ; while late activation provoke the generation of pro-inflammatory IL-1 family members including IL-1 , IL-6 and IL-33', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': '.', 'entities': {}, 'relations': {}},\n",
       "       {'Section': 'METHODS', 'text': 'Here , we propose for the first time that inflammation by coronavirus maybe inhibited by anti-inflammatory cytokines belonging to the IL-1 family members .', 'entities': {'entity_1': {'text': 'inflammation', 'class': 'Outcome', 'negation': 0, 'UMLS': '', 'start': 9}, 'entity_2': {'text': 'coronavirus', 'class': 'Participant', 'negation': 0, 'UMLS': '', 'start': 11}, 'attribute_1': {'text': 'inhibited', 'class': 'modifier', 'negation': 0, 'UMLS': '', 'start': 13}}, 'relations': {}}],\n",
       "      dtype=object)"
      ]
     },
     "execution_count": 140,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "file = \"32013309.json\"\n",
    "file_path = os.path.join(folder, file)\n",
    "temp = pd.read_json(file_path)\n",
    "    \n",
    "temp.sentences.values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 141,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[('TITLE',\n",
       "  'Mast cells contribute to coronavirus-induced inflammation: new anti-inflammatory strategy.'),\n",
       " ('BACKGROUND',\n",
       "  'Coronavirus can cause respiratory syndrome which to date has affected about twelve thousand individuals , especially in China .'),\n",
       " ('RESULTS',\n",
       "  'Coronavirus is interspecies and can also be transmitted from man to man , with an incubation ranging from 1 to 14 days .'),\n",
       " ('RESULTS',\n",
       "  'Human coronavirus infections can induce not only mild to severe respiratory diseases , but also inflammation , high fever , cough , acute respiratory tract infection and dysfunction of internal organs that may lead to death .'),\n",
       " ('RESULTS',\n",
       "  'Coronavirus infection ( regardless of the various types of corona virus ) is primarily attacked by immune cells including mast cells ( MCs ) , which are located in the submucosa of the respiratory tract and in the nasal cavity and represent a barrier of protection against microorganisms .'),\n",
       " ('RESULTS',\n",
       "  'Viral activate MCs release early inflammatory chemical copounds including histamine and protease ; while late activation provoke the generation of pro-inflammatory IL - 1 family members including IL - 1 , IL - 6 and IL - 33 .'),\n",
       " ('CONCLUSIONS',\n",
       "  'Here , we propose for the first time that inflammation by coronavirus maybe inhibited by anti-inflammatory cytokines belonging to the IL - 1 family members .')]"
      ]
     },
     "execution_count": 141,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "sections.get(\"32013309\")"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Send counters to pickle file"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 142,
   "metadata": {
    "scrolled": true
   },
   "outputs": [],
   "source": [
    "ent_df = pd.read_csv(\"LitCovid_treatment_ents.csv\")\n",
    "p_count = Counter(ent_df[ent_df.type == \"Participant\"].text.values)\n",
    "i_count = Counter(ent_df[ent_df.type == \"Intervention\"].text.values)\n",
    "o_count = Counter(ent_df[ent_df.type == \"Outcome\"].text.values)\n",
    "\n",
    "counters = [p_count, i_count, o_count]\n",
    "c_names = [\"p_count\", \"i_count\", \"o_count\"]\n",
    "for i in range(len(counters)):\n",
    "    with open(\"Pickles/\" + c_names[i] + '.pickle', 'wb') as file:\n",
    "        pickle.dump(counters[i], file)\n",
    "    "
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "# Building weighted graph"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      " 28%|█████████████████▊                                              | 33980/121669 [03:07<12:23, 117.86it/s]"
     ]
    }
   ],
   "source": [
    "from collections import Counter\n",
    "import itertools as it\n",
    "\n",
    "# get data and group\n",
    "ent_df = pd.read_csv(\"LitCovid_treatment_ents.csv\")\n",
    "g = ent_df.groupby([\"pmid\", \"type\"])\n",
    "\n",
    "#initialize variables\n",
    "groups = list(g.groups)\n",
    "types = [\"Participant\", \"Outcome\", \"Intervention\"]\n",
    "edge_weight = Counter()\n",
    "nodes = []\n",
    "\n",
    "for p in tqdm(ent_df.pmid.values):\n",
    "    temp = []\n",
    "    for tup in list(it.product([p], types)):\n",
    "        if tup in groups:\n",
    "            \n",
    "            #get pmid entities\n",
    "            grp = g.get_group(tup)\n",
    "            \n",
    "            #format appropriately\n",
    "            temp_nodes = [\"{} ({})\".format(t, tup[1][0]) for t in grp.text.values]\n",
    "            temp.append(temp_nodes)\n",
    "            nodes += temp_nodes\n",
    "        else:\n",
    "            temp.append([])\n",
    "            \n",
    "    #get edges\n",
    "    products = [list(it.product(temp[0], temp[1])), list(it.product(temp[0], temp[2])), list(it.product(temp[1], temp[2]))]\n",
    "    \n",
    "    #add edges to adj list\n",
    "    for prod in products:\n",
    "        if prod != []:\n",
    "            edge_weight.update(prod)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open(\"Pickles/\" + 'wb') as file:\n",
    "    pickle.dump(edge_weight, file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "with open('edges.pickle', 'rb') as file:\n",
    "    edge_weight = pickle.load(file)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {},
   "outputs": [],
   "source": [
    "import networkx as nx\n",
    "from pyvis.network import Network\n",
    "import matplotlib.pyplot as plt\n",
    "\n",
    "G = nx.Graph()\n",
    "for item in edge_weight.most_common(200):\n",
    "    G.add_edge(item[0][0], item[0][1], weight=item[1]*100)\n",
    "\n",
    "\n",
    "\n",
    "g = Network(height=800, width=800, notebook=True)\n",
    "g.barnes_hut()\n",
    "g.from_nx(G)\n",
    "g.show_buttons(filter_=['physics'])\n",
    "g.show(\"ex.html\")\n",
    "\n"
   ]
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 3",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.7.0"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 2
}
